View

Can a diabetes drug fix a weak heart without making you lose weight?

Original Title

Abstract 4359454: Low-Dose Semaglutide Attenuates Cardiac Lipid Content and Hepatic Steatosis in Cardiometabolic HFpEF: Weight Loss Independent Actions of GLP-1 Receptor Activation

doi:10.1161/circ.152.suppl_3.4359454
16%

Lower Quality

Methodology score · 16/100

Rct Animal
Fit Body Science breakdown

We translate health research into clear, actionable insights. Here’s what this study found and what it means for you.

Not medical advice. For informational purposes only. Always consult a healthcare professional.

What’s the bottom line?

A diabetes drug called semaglutide helped hearts and livers of overweight animals with heart failure work better—even when they didn’t lose any weight.

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Score breakdown, methodology, COI, evidence analysis & raw study data